Wonderland Labs Blog
The DEA Emergency-Banned 3 Synthetic Kratom Compounds: What You Need to Know
The federal landscape for manufactured kratom products has shifted dramatically. On August 25, 2026, the U.S. Drug Enforcement Administration (DEA) issued a temporary emergency scheduling order placing three highly potent, synthetic kratom-related compounds into...
Federal Changes in Kratom Scheduling Status
Subject: Important Regulatory Update: Testing Availability for MGM-15, MGM-16, and Mitragynine Pseudoindoxyl --- 1. The Federal Regulatory Status (Clarification) July 6, 2026 (Notice of Intent): The U.S. Drug Enforcement Administration (DEA) published a formal Notice...
How to Track Kratom Regulatory Updates: Federal Register and Florida Compliance Portals
How to Track Real-Time Kratom Regulatory Updates: Federal Register & Florida Compliance Portals In an era of rapid emergency rulemaking, staying ahead of regulatory changes is an operational necessity for quality assurance managers, analytical laboratories,...
Florida’s Emergency Kratom Regulations: Rules 2ER26-1 and 5KER26-9
Florida’s Emergency Kratom Regulations: Rules 2ER26-1, 5KER26-9, and the Analytical CRM Bottleneck Florida has established itself as one of the most aggressive state regulatory environments for botanical supplements and novel alkaloid products. Through joint action...
The Federal 7-OH Temporary Scheduling Order: Thresholds, Legal Limits, and Regulatory Impact
The Federal 7-OH Temporary Scheduling Order: DEA Docket DEA-1570, Concentration Thresholds, and Laboratory Compliance The regulatory landscape for Mitragyna speciosa and its derived alkaloids has reached a historical turning point. Following months of heightened...
Slight Wording Change on Kratom COA’s
Clients, Wonderland Labs unintentionally placed a phrase on our recent COAs that may have implied a scientific opinion that we do not possess. Instead of including the full chemical name after the MGM-15 table entry, we included a Google result of "MGM-15...
SR-17018: Testing the Untestable
SR-17018 is a synthetic, G protein-biased mu-opioid receptor agonist developed to test whether separating Gi signaling from β-arrestin recruitment could yield safer analgesics. This article covers its pharmacology, preclinical findings, and analytical characterization.
Pseudoindoxyl Testing Done Right
Wonderland labs specializes in testing Kratom and Kava and offer both 7OH and pseudoindoxyl testing as part of the standard ID/Potency tests. No one puts nearly as much precision and attention into the results we provide, doing complementary re-runs and re-tests whenever the results do not match the expected.
Who to Trust With Kratom Testing
One of the most difficult questions facing those who need to get testing completed for their Kratom is which lab to trust. How can you know which lab is the right choice? No one puts nearly as much precision and attention into the results we provide, doing complementary re-runs and re-tests whenever the results do not match the expected.
Kratom Testing Variances Between Labs
How can there be variance in Kratom testing results between labs? Find out in this extensively detailed and referenced article.